Pharmaceutical cold chain logistics providers play a vital role in getting temperature sensitive medicines safely to you. Em 2024 o mercado de logística da cadeia de frio farmacêutica atingiu US$ 18,61 bilhões e prevê-se que ultrapasse US$ 27 bilhões por 2033. Biopharmaceuticals account for roughly 30 % de todas as drogas, and many require storage at 2 °C–8 °C, –20 °C ou mesmo cryogenic temperatures below −150 °C. Any deviation, even 30 minutos, can degrade a vaccine. This guide explains what the pharma cold chain is, highlights the top providers and innovations, and offers practical advice for choosing the right logistics partner in 2025.
O que é a cadeia de frio farmacêutica e por que isso é importante? — a clear overview of temperature control and compliance.
Who are the leading pharma cold chain logistics providers? — profiles of UPS, DHL, FedEx and other key players with recent expansions.
What technologies and packaging innovations are transforming the cold chain? — IoT sensors, IA, reusable packaging and more.
How is the market evolving across regions and segments? — growth forecasts for Europe, América do Norte, India and Asia Pacific.
What challenges and opportunities define the supply chain? — from temperature excursions to sustainability.
Perguntas frequentes about GDP compliance, provider selection and more.
O que é a cadeia de frio farmacêutica e por que isso é importante?
Resposta direta
Pharma cold chain logistics providers maintain the integrity of temperature sensitive medicines by storing, transporting and monitoring them within strict temperature bands. These bands typically include 2 °C–8 °C (refrigerado), abaixo de −20 °C (congelado) e cryogenic conditions below −150 °C for cell and gene therapy products. Biologics now represent sobre 30 % de todas as drogas, so protecting them from temperature excursions is critical to patient safety and regulatory compliance.
Explicação expandida
Imagine a relay race where the baton is your vaccine. Each runner must pass it without letting it warm up or freeze. Pharma cold chain logistics companies coordinate this relay from manufacturing to patient delivery, usando armazéns refrigerados, recipientes isolados, veículos com temperatura controlada e monitoramento em tempo real. Eles monitoram a temperatura, humidity and location via IoT sensors and digital control towers so that deviations are caught immediately. Conformidade com Boas Práticas de Distribuição (PIB) and other regulations ensures that all steps—from packaging to documentation—are validated. Without this infrastructure, sensitive biologics like insulin, vaccines and gene therapies would lose potency, risking public health.
Elementos-chave de uma cadeia de frio farmacêutica
| Elemento | Propósito | Significado prático |
| Armazenamento com temperatura controlada | Uses refrigerated warehouses, cryogenic freezers and insulated rooms to hold products at 2 °C–8 °C, –20 °C ou –150ºC | Maintains drug efficacy during inventory periods |
| Embalagem isolada | Remetentes descartáveis e reutilizáveis com materiais de mudança de fase protegem as remessas durante o trânsito | Evita excursões de temperatura; enables last mile delivery even at –70 °C |
| Monitoramento em tempo real | Sensores de IoT, Etiquetas RFID e plataformas em nuvem registram temperatura, umidade e localização continuamente | Provides early alerts; research shows ~80 % of cold chain shipments use real time monitoring |
| Coordenação logística | Planejamento de rota, desembaraço aduaneiro e documentação garantem entrega pontual | Minimises delays; essencial para cadeias de abastecimento globais |
| Conformidade regulatória | Adhering to GDP, ISO certifications and regional regulations guides equipment and processes | Reduz o risco jurídico e garante a qualidade em todas as regiões |
Dicas práticas e exemplo de caso
Defina seu perfil de temperatura: Determine se seus produtos precisam ser refrigerados (2–8 ° C.), congelado (abaixo de −20 °C) ou criogênico (<−150°C) transporte. Select providers certified for those ranges.
Pergunte sobre monitoramento: Choose companies offering real time temperature and location tracking. IoT enabled control towers can prevent product loss.
Confirme a conformidade com o PIB: Garantir que os fornecedores possuam certificações relevantes (por exemplo, ISO 9001, PIB).
Considere a sustentabilidade: Embalagens reutilizáveis e veículos energeticamente eficientes reduzem o desperdício e podem reduzir custos.
Planeje o alcance global: Work with providers experienced in customs documentation and multimodal transport.
Estudo de caso: Em Fevereiro 2024, Sensitech lançada TempTale GEOX, um monitor de temperatura habilitado para IoT adaptado para logística de ciências biológicas. The device provides real time analytics across air, oceano, embarques rodoviários e ferroviários. Such innovations demonstrate how technology enhances visibility and compliance.
Qual é o tamanho do mercado de logística da cadeia de frio farmacêutica?
Market overview
The pharmaceutical cold chain logistics market reached US$18.61 billion in 2024 and is projected to grow to US$27.11 billion by 2033, at a compound annual growth rate (Cagr) de 4.3 %. The broader healthcare cold chain logistics sector—including medical devices and blood products—was US$ 59,97 bilhões em 2024, rose to US$ 65,14 bilhões em 2025 and is expected to surpass US$137 billion by 2034. O crescimento é impulsionado pela crescente demanda por produtos biológicos e vacinas, padrões regulatórios mais rígidos e investimento em monitoramento e embalagem avançados.
Regional snapshot
| Região | 2024/25 tamanho do mercado | Previsão de crescimento & motoristas | Implicações práticas |
| Europa | ~US$ 19,39 bilhões em 2024 aumentando para US$ 21,55 bilhões em 2025 | Espera-se alcançar US$ 34,7 bilhões por 2030 at ~10 % Cagr; alta demanda por armazenamento ultrafrio devido a produtos biológicos e terapias genéticas | Os fornecedores devem investir em capacidade criogênica e cumprir as rigorosas regulamentações do PIB da UE |
| América do Norte | A espinha dorsal da cadeia de frio global | Major investments by UPS, DHL and other integrators; dominado pelos EUA. remessas de produtos biológicos e vacinas | Emphasis on end to end logistics and integration with clinical trials |
| Índia | US$ 0,57 bilhão em 2024 com 3.2 % CAGR para alcançar US$ 0,8 bilhão por 2033 | Government initiatives like the National Cold Chain Management Information System encourage investment | Opportunity for last mile improvements and local partnerships |
| Ásia-Pacífico | Região de crescimento mais rápido | Driven by vaccine distribution programmes and biologics manufacturing | Providers like DHL and Lineage are expanding; reusable packaging adoption is rising |
Beyond these regions, **North America is expected to dominate the global cold chain market with a 42.87 % compartilhar em 2024. O cryogenic segment, which includes temperatures below −150 °C, is forecast to capture 31.45 % da participação de mercado because mRNA vaccines, gene therapies and CAR T cell therapies require ultra low temperatures. Innovations like CSafe’s Dewars multiuso, launched in abril 2024, manter –150ºC and include real time tracking for cell and gene therapies.
Leading pharma cold chain logistics providers in 2025
Visão geral
The pharmaceutical cold chain ecosystem comprises third party logistics (3Pl) integrators, despachantes, especialistas em embalagens e fabricantes de equipamentos. Major logistics providers include UPS Cuidados de Saúde, DHL Ciências da Vida & Assistência médica, FedEx, AmerisourceBergen, Cardeal Saúde, Kuehne + Nagel, CEVA Logística, VersaCold and Lineage. Packaging and equipment innovators such as Tecnologias da cadeia fria (CCT), C Safe Global, Pelicano Biotérmico, Ambiente, DS Smith, Azenta and Thermo Fisher Scientific complement these providers with insulated shippers, Recipientes reutilizáveis, cryogenic equipment and monitoring solutions.
Third party logistics and integrators
UPS Cuidados de Saúde – In 2025 UPS expanded its cold chain capabilities by acquiring Germany’s Frigo Trans and BPL, adicionando armazenamento pan-europeu com temperatura controlada e encaminhamento de carga de tempo crítico. UPS invested more than €20 million in 2024 para adicionar mais 200 veículos com temperatura controlada e doubled its global healthcare distribution space to 1.7 milhões de m². Em abril 2025 it agreed to buy Canada’s Andlauer Healthcare Group for US$1.6 billion, adicionando nove centros de distribuição e 22 galhos. A case study notes that UPS’s acquisitions provided temperature controlled warehousing ranging from –196 °C to +25 °C and enhanced end to end services.
DHL Ciências da Vida & Assistência médica – DHL acquired CryoPDP in March 2025 para integrar remessas sensíveis à temperatura, armazenamento e embalagem e fortalecer sua atuação nos EUA. presença. DHL operates sobre 150 healthcare logistics facilities globally and emphasises sustainable packaging and alternative fuels. A separate report noted that DHL is investing €2 billion de 2025 para 2030 to expand cold chain capacity, build GDP certified hubs and introduce digital tools.
FedEx – FedEx continues to expand cold chain capacity via its Express and Custom Critical units, fornecendo carga aérea e serviços terrestres com temperatura controlada. A empresa investe em IoT sensors and blockchain traceability, e em Janeiro 2025 it announced partnerships with leading pharma manufacturers to distribute biologics and mRNA vaccines in remote areas.
Kuehne + Nagel and CEVA Logistics – Both offer GDP compliant warehouses, embalagem e entrega de última milha. Kuehne + Nagel expanded its pharma distribution footprint in Asia with new facilities in India and China in novembro 2024.
VersaCold and Lineage Logistics – These North American cold storage specialists operate extensive networks. Linhagem integrates warehouse robotics and smart software to optimise energy consumption and maintain temperature integrity. VersaCold focuses on end to end solutions for food and pharmaceuticals and is expanding across North America and Asia.
AmerisourceBergen and Cardinal Health – These pharmaceutical distributors provide high volume shipments to hospitals and pharmacies and manage sistemas de monitoramento em tempo real through their Sonoco ThermoSafe subsidiary. AmerisourceBergen launched a blockchain enabled track and trace system in December 2024.
Especialistas em embalagens e equipamentos
Tecnologias da cadeia fria (CCT) – Known for reusable pallet shippers, CCT launched the CCT Tower Elite system at LogiPharma 2025 and released a reusable pallet shipper in April 2025. This system reduces waste and provides long duration thermal protection.
C Safe Global – Manufactures active container systems with controlled heating and cooling for air and ground transport, manutenção 2 °C–8 °C e 15 °C–25 °C para até 120 horas.
Pelicano Biotérmico – Offers Credo Cube reusable shippers and single use CoolPall boxes with integrated data loggers for temperature tracking.
Ambiente – Provides active air cargo containers using compressor driven cooling and battery power to maintain stable temperatures. UPS executives cite Envirotainer as essential for last mile delivery at −70°C.
DS Smith – Introduced TailorTemp, a fibre based packaging solution providing up to 36 horas de estabilidade térmica, na Pharmapack Europa 2025. O uso de fibra reduz o desperdício de plástico e aumenta a reciclabilidade.
Azenta (anteriormente Brooks Automation) & Termo Fisher Científico – Expanded cold chain capabilities by acquiring B Sistemas médicos, oferecendo soluções automatizadas de armazenamento e transporte criogênico. CSafe (uma subsidiária da Thermo Fisher) introduzido Dewars multiuso with real time tracking to support cell and gene therapy distribution at –150ºC.
Provedores de tecnologia e monitoramento
Empresas como Sensitech e TransVoyant develop IoT devices and AI powered control towers. Sensitech’s TempTale GEO X provides real time analytics across multiple transport modes, enquanto TransVoyant e CargoSense create digital twins that predict disruptions. Tag N Trac develops smart trackers with Bluetooth and cellular connectivity.
Como as empresas líderes se diferenciam
| Empresa | Serviços principais | Diferenciadores | Benefício prático |
| UPS Cuidados de Saúde | Transporte global da cadeia de frio, warehousing and supply chain integration | Aquisições agressivas (Frigo Trans, BPL, Andlauer), fleet expansion and end to end visibility | Rede mais ampla e capacidade criogênica; redução da perda de produto por meio de monitoramento integrado |
| DHL Ciências da Vida & Assistência médica | Transporte aéreo e terrestre com temperatura controlada, armazenar, embalagem | Aquisição do CryoPDP; foco em embalagens sustentáveis e combustíveis alternativos | Gama de serviços melhorada e conformidade ambiental |
| Cardeal Saúde & AmerisourceBergen | Distribuição farmacêutica, 3Serviços de PL, embalagem especializada (Sonoco ThermoSafe) | Blockchain enabled track and trace system | Reliable distribution to hospitals; improved security and regulatory compliance |
| Linhagem & VersaCold | Armazenagem frigorífica e logística | Redes de instalações com robótica de armazém e software inteligente | Operações com eficiência energética e escalabilidade |
| Tecnologias da cadeia fria (CCT) | Insulated shippers and reusable pallets | CCT Tower Elite e inovações em transportadores de paletes reutilizáveis | Reduced waste and improved thermal performance |
| Ambiente | Active air cargo containers | Resfriamento acionado por compressor; energia da bateria por longa duração | Mantém temperaturas criogênicas no frete aéreo; essencial para terapias genéticas |
| Azenta & Termo Fisher | Cryogenic equipment and automation | Aquisição da B Medical Systems; automated storage and real time tracking dewars | Enables cell and gene therapy distribution and long term biobank storage |
Dicas práticas ao selecionar um parceiro logístico
Avalie o alcance da rede: Escolha um fornecedor com instalações próximas aos locais de fabricação e aos locais dos clientes para reduzir os tempos de trânsito.
Avalie o compromisso com a inovação: Procure empresas que investem em IoT, IA e embalagens reutilizáveis; essas ferramentas reduzem o risco e o impacto ambiental.
Verifique M&Uma atividade: Aquisições recentes sinalizam crescimento e capacidades expandidas; ensure the company integrates new assets smoothly.
Verifique as políticas de sustentabilidade: Partners using circular packaging and electric or biofuel fleets can improve your ESG profile.
Technology and packaging innovations shaping pharma cold chain logistics
Resposta direta
Pharma cold chain logistics is being transformed by IoT sensors, Torres de controle acionadas por IA, rastreabilidade de blockchain, embalagem reutilizável, fibre based materials and smart labels. These innovations improve visibility, reduzir o desperdício e garantir a conformidade.
Explicação expandida
IoT devices and digital twins: Sensores coletam temperatura, dados de umidade e localização, while digital twins and AI predict disruptions and adjust routes. Por exemplo, Merck’s Global Health Innovation Fund invested in TransVoyant and CargoSense to deploy AI powered control towers that saved critical shipments during the pandemic.
Blockchain platforms: Livros distribuídos registram dados de temperatura e cadeia de custódia, simplifying audits and preventing counterfeiting. AmerisourceBergen’s blockchain enabled track and trace system launched in December 2024 exemplifies this trend.
Sistemas de embalagens reutilizáveis: Shippers like Torre CCT Elite e Pelican’s Credo Cube pode ser reutilizado várias vezes, reducing waste and total cost of ownership. DS Smith’s TailorTemp uses fibre based materials to provide até 36 horas de estabilidade térmica while reducing plastic consumption.
Dewars criogênicos com rastreamento em tempo real: CSafe’s Dewars multiuso manter –150ºC for cell and gene therapies and include a built in TracSafe real time tracking device.
Rótulos inteligentes & resfriamento ativo: Emerging innovations include satellite enabled labels and wireless charged boxes that allow global tracking and energy efficient cooling.
Tabela de inovações notáveis
| Inovação | Descrição | Impacto na logística da cadeia de frio |
| Sensores habilitados para IoT & torres de controle | Sensores coletam temperatura, dados de umidade e localização; gêmeos digitais e IA prevêem interrupções | Melhora a visibilidade, reduz a deterioração e permite respostas proativas |
| Sistemas de embalagens reutilizáveis | Shippers like CCT Tower Elite and Pelican Credo Cube can be reused for multiple shipments | Reduz o desperdício, reduz o custo total de propriedade e apoia a sustentabilidade |
| Embalagem à base de fibra (TailorTemp) | DS Smith’s TailorTemp uses paper based materials and provides up to 36 horas of thermal protection | Minimiza o consumo de plástico e simplifica a reciclagem |
| Cryogenic dewars with tracking | CSafe’s Multi Use Dewars maintain –150 °C or colder and include real time tracking | Ensures ultra low temperatures for cell and gene therapies and compliance |
| Blockchain & certificados digitais | Livros distribuídos registram dados de temperatura e cadeia de custódia | Melhora a rastreabilidade, auditoria de segurança e regulatória |
| Rótulos inteligentes & resfriamento ativo | Inovações futuras incluem etiquetas habilitadas para satélite e caixas carregadas sem fio | Provides global tracking and reduces energy consumption |
Dicas práticas para adotar novas tecnologias
Pilotar novas soluções: Teste dispositivos IoT ou transportadores reutilizáveis em pequenas remessas para medir o desempenho antes da implantação completa.
Integre sistemas de dados: Ensure monitoring devices interface with your warehouse management or ERP systems.
Treine a equipe: A implementação de IA e blockchain requer novos fluxos de trabalho; provide training so teams can interpret data and act on alerts.
Planeje a logística reversa: Embalagens reutilizáveis e rótulos inteligentes exigem processos de devolução; coordinate with carriers for efficient returns.
Dinâmica da cadeia de abastecimento, desafios e oportunidades
Cost and operational dynamics
Pharmaceutical cold chain logistics account for 7–10 % dos custos totais da cadeia de abastecimento farmacêutico, e 40–60 % dos gastos gerais com logística dedica-se ao transporte e armazenamento. Despite advancements in automation and IoT, os desafios permanecem:
Excursões de temperatura: Em volta 4 % das remessas estão comprometidas e 40 % de falhas na cadeia de frio decorrem de um monitoramento deficiente.
Fragmented monitoring: When multiple carriers handle shipments, real time visibility can be lost.
Complexidade regulatória: Different regions impose varying guidelines for packaging, rotulagem e documentação.
Infrastructure gaps: Emerging markets often lack reliable cold storage or transportation.
Escassez de talentos: Skilled labour for handling biologics is scarce; the global life sciences supply chain workforce is projected to grow 60 % por 2025.
Oportunidades
Automação e IA: Robotics and AI optimise warehouse operations, reducing labour costs and human error.
Embalagem reutilizável: Circular systems reduce waste and support corporate sustainability goals.
Energia renovável & electrification: Electric and biofuel fleets, as well as ammonia based refrigeration, menores pegadas de carbono.
Blockchain & gêmeos digitais: Provide tamper proof traceability and predictive insights.
Real world challenges and solutions
Excursões de temperatura: Use sensores redundantes e alertas em tempo real; implement corrective protocols immediately.
Complexidade regulatória: Faça parceria com fornecedores com experiência em navegar em regulamentações internacionais; maintain documentation and continuous training.
Infrastructure gaps: Collaborate with local operators and invest in mobile cold rooms or solar powered freezers.
Escassez de talentos: Automatize processos de armazenamento e transporte; offer continuous training and incentives.
Regional growth patterns and 2025 tendências
Resposta direta
A Europa e a América do Norte dominam atualmente a cadeia de frio farmacêutica, but Asia Pacific and India are growing fastest. O mercado europeu deverá atingir US$ 34,7 bilhões por 2030 with a ~10 % Cagr, and about 80 % of pharmaceutical products in Europe require temperature controlled transport. North America remains the backbone due to massive investments by UPS, DHL and Lineage and a high demand for biologics. India’s segment is expected to grow at 3.2 % anualmente, alcançando US$ 0,8 bilhão por 2033, while Asia Pacific is the fastest growing region thanks to vaccine distribution and biologics manufacturing.
Visão geral das tendências
Rise of biologics and cell gene therapies: Approvals of new biologics, gene therapies and CAR T cell treatments increase demand for ultra cold or cryogenic storage. The cryogenic segment holds 31.45 % da participação de mercado.
Increasing mergers and acquisitions: UPS’s acquisitions of Frigo Trans, BPL and Andlauer and DHL’s acquisition of CrioPDP show how major players expand networks to meet growing demand.
Transformação digital: Control towers, digital twins and IoT sensors provide predictive analytics and end to end visibility.
Foco na sustentabilidade: Remetentes reutilizáveis, fibre based packaging and electrified fleets reduce environmental impact.
Atualizações regulatórias: Em 2025 os EUA. Lei de Segurança da Cadeia de Abastecimento de Medicamentos (DSCSA) transitions to full interoperability with deadlines for manufacturers (Poderia 27), atacadistas (Aug 27) and large dispensers (Nov 27). Europe enforces the Falsified Medicines Directive and updates to GDP guidelines. O WHO Model Guidance on Controlled Room Temperature e ICH Q12/Q13 encourage harmonisation.
Innovation in packaging: DS Smith’s TailorTemp, CCT Tower Elite and Multi Use Dewars illustrate how fibre based materials and reusable containers deliver long duration thermal stability.
Market insights and consumer preferences
Consumers and regulators increasingly demand sustainability. UM 2025 industry review notes that temperature controlled logistics account for 23 % of pharmaceutical transportation budgets, acima de 18 % em 2020. Temperature excursions cause US$35 billion in losses annually with a 12 % product recall rate. Consequentemente, pharmaceutical companies are adopting recyclable insulated containers, envoltórios biodegradáveis e compressas frias reutilizáveis. Renewable power and electrified fleets are helping reduce carbon footprints.
Perguntas frequentes
Q1: What is Good Distribution Practice (PIB) e por que é importante?
Good Distribution Practice is a quality system that governs the wholesale distribution of medicinal products. It requires companies to maintain proper temperature control, accurate record keeping, validated equipment and trained staff. Compliance reduces the risk of product degradation and regulatory penalties.
Q2: How do I choose the right pharma cold chain logistics provider?
Avalie seus requisitos de temperatura (refrigerado, congelado, criogênico), network reach, monitoring capabilities and certifications. Look for providers investing in IoT, IA e embalagens sustentáveis. Evaluate their M&A activity and track record for integrating new assets.
Q3: Why are real time monitoring and IoT important?
Real time monitoring uses sensors and cloud platforms to track temperature, humidity and location throughout the journey. Aproximadamente 80 % of cold chain shipments now use real time monitoring. It enables immediate action when deviations occur, reduzindo a deterioração.
Q4: What are sustainable packaging options for pharmaceuticals?
Sustainable options include remetentes reutilizáveis (Torre CCT Elite, Credo Cube), fibre based containers (TailorTemp), biodegradable wraps and reusable cold packs. These reduce waste and support circular supply chains.
Q5: How will regulation change in 2025?
O DSCSA introduces full interoperability for the U.S. drug supply chain with serialization and traceability requirements. Europe enforces the Falsified Medicines Directive and updates to GDP guidelines. Companies must invest in data systems and training to comply.
Q6: Do I need cryogenic logistics for all biologics?
Not all biologics require cryogenic temperatures. Many monoclonal antibodies and vaccines remain stable at 2–8 °C or –20 °C. Cryogenic logistics (below –150 °C) are essential for cell and gene therapy products like mRNA vaccines and CAR T therapies.
Resumo & Recomendações
The pharmaceutical cold chain has become a strategic priority as biologics and gene therapies proliferate. Em 2024 the market reached US$18.61 billion and is forecast to exceed US$27 billion by 2033, driven by stricter regulations and rising demand for temperature sensitive therapies. Top providers such as UPS, DHL e FedEx have expanded through acquisitions, increasing cryogenic capacity and digital capabilities. Packaging innovators are introducing reusable and fibre based solutions that deliver long duration thermal stability. To choose a provider, assess your temperature requirements, network reach, innovation commitment and sustainability policies. Investing in IoT, AI and blockchain will enhance visibility and compliance. Sustainable practices like reusable containers and electrified fleets not only reduce emissions but also improve cost efficiency. By aligning with these trends, you can ensure safe deliveries while meeting regulatory and environmental expectations.
ACTO ACEDIVO PRÓXIMO PASSOS
Mapeie seu portfólio de produtos: Classify each drug by required temperature range (2–8 ° C., –20 °C, criogênico) e volume. This determines the type of logistics services and packaging needed.
Conduct a provider audit: Use the evaluation criteria above to shortlist providers. Request information on their certifications, sistemas de monitoramento, fleet composition and sustainability programmes.
Pilot digital solutions: Implement IoT sensors or blockchain pilots on a small scale to evaluate performance before full deployment.
Set sustainability goals: Define targets for reusable packaging adoption, carbon reduction and waste minimisation. Work with providers offering circular packaging and electrified fleets.
Fique à frente dos regulamentos: Train staff on GDP, DSCSA and regional guidelines. Invest in data systems to meet serialization and track and trace requirements.
Sobre Tempk
Tempk is a specialist in cold chain packaging solutions. Our mission is to make temperature controlled logistics simpler and more sustainable. We offer caixas isoladas, bolsas de gelo em gel, VIP shippers and reusable container systems designed to maintain stable temperatures across the entire shipping journey. Our products are backed by rigorous testing and certifications to meet GDP and ISO standards. By focusing on energy efficiency and recyclable materials, we help you reduce waste and lower costs while protecting patient safety. Partner with Tempk to build a resilient, compliant and environmentally friendly cold chain.
PRÓXIMOS PASSOS
Ready to safeguard your biologics? Contact our team for a consultation and discover how Tempk’s solutions can be tailored to your needs. Our specialists will analyse your shipping requirements, recommend the right packaging, and help you navigate regulatory and sustainability challenges.
